Agilysys Announces Mandatory Conversion Date for Series A Convertible Preferred Stock
ALPHARETTA, Ga.–(BUSINESS WIRE)–Agilysys, Inc. (Nasdaq: AGYS) announced today that it has delivered a notice of mandatory conversion to the holders of... Read more.
Hudson Therapeutics, Inc. Appoints Janice Marie McCourt as co-Chief Executive Officer and Board Member
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Hudson Therapeutics, Inc., a biotechnology company specializing in anti-inflammatory and immuno-oncology... Read more.
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments... Read more.
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments... Read more.
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
LA JOLLA, Calif.–(BUSINESS WIRE)–$LBPH #Epilepsy—Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused... Read more.
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
Promising anti-tumor activity in heavily pretreated clear cell renal cell carcinoma (ccRCC) patients Objective response rate (ORR) of 21.4% and disease control rate... Read more.
Cimeio Therapeutics Announces Poster Presentations at ASH 2023
– CD45 ADC effectively eliminates AML cells in vivo, while CD45 epitope-edited healthy cells were shielded from ADC depletion – BASEL, Switzerland &... Read more.
Trane Technologies Completes Acquisition of Connected Workplace and Enterprise Asset Management Leader Nuvolo
SWORDS, Ireland–(BUSINESS WIRE)–Trane Technologies (NYSE: TT), a global climate innovator, has completed the acquisition of Nuvolo, a global leader in... Read more.
Blizzard Entertainment Announces the Next Three Expansions for World of Warcraft®, Kicking Off The Worldsoul Saga™ with The War Within™ in 2024
The most ambitious creative endeavor for World of Warcraft since its release almost 20 years ago The War Within is available for pre-purchase today, includes access... Read more.
AM Best Assigns Issue Credit Ratings to Humana Inc.’s Senior Unsecured Notes
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of “bbb” (Good) to the recently... Read more.